Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

7 Excellent Retirement Funds for Your Portfolio if You’re 50-Plus

By Josh Enomoto, InvestorPlace Contributor

With all that has transpired in our nation and throughout the world, it’s easy to be distracted from retirement investing. Nevertheless, investors should regain their focus and concentrate on retirement funds.

Do You Love Your Pets That Much for Zomedica Stock to Be Worth Billions?

By Josh Enomoto, InvestorPlace Contributor

While the pet care industry is a compelling one, ZOM stock occupies one of its riskiest subsegments, making the narrative insanely treacherous.

8 Cheap Stocks Under $20 That Could Double

By Josh Enomoto, InvestorPlace Contributor

Even though the market has been on fire recently, that doesn’t mean you’re too late to pick up cheap stocks under $20 with 2x (or more) potential.

Y’all Are Missing the Point About GameStop

By Josh Enomoto, InvestorPlace Contributor

While GME stock has been wildly profitable for day traders, the sideshow that it incurred detracts from its compelling fundamental narrative.

BioNano Genomics Is in a Perfect Bull-Bear Tug of War

By Josh Enomoto, InvestorPlace Contributor

Among all the biotech pivots toward the novel coronavirus, BNGO stock represents one of the most sensible. But does that mean shares are a buy?

Load More